In insulin-resistant ob/ob mice, metformin improves fatty liver disease, possibly by attenuating hepatic expression of TNF-α, which promotes insulin resistance and plays a role in hepatocarcinogenesis [128]. The gene discussed is TNF; the disease is Insulin resistance.